Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA drug recalls in 2015

Every FDA drug recall initiated in 2015, newest first, with its risk class, status and the reason the FDA recorded. Use the cause and risk filters to narrow the year down.

1,733 recalls, newest first.

Class II · Moderate risk

Dexamethasone 0.4% Opth Ointment

Lack of Assurance of Sterility: A recall of all compounded sterile preparations within expiry is being initiated due to observations associated with poor sterile production practices resulting in a lack of sterility assurance for their finished drugs.

Terminated Sterility / contamination Kalman Health & Wellness, Inc. dba Essential Wellness Pharma D-303-2016
Class II · Moderate risk

Cyclosporin 0.1% Opth Solution

Lack of Assurance of Sterility: A recall of all compounded sterile preparations within expiry is being initiated due to observations associated with poor sterile production practices resulting in a lack of sterility assurance for their finished drugs.

Terminated Sterility / contamination Kalman Health & Wellness, Inc. dba Essential Wellness Pharma D-302-2016
Class II · Moderate risk

BIMIX INJ 30 mg-1 mg/mL Injection

Lack of Assurance of Sterility: A recall of all compounded sterile preparations within expiry is being initiated due to observations associated with poor sterile production practices resulting in a lack of sterility assurance for their finished drugs.

Terminated Sterility / contamination Kalman Health & Wellness, Inc. dba Essential Wellness Pharma D-301-2016
Class II · Moderate risk

17-Alpha Hydroxyprogesterone 250 mg/mL in Sesame Oil Injection

Lack of Assurance of Sterility: A recall of all compounded sterile preparations within expiry is being initiated due to observations associated with poor sterile production practices resulting in a lack of sterility assurance for their finished drugs.

Terminated Sterility / contamination Kalman Health & Wellness, Inc. dba Essential Wellness Pharma D-300-2016
Class II · Moderate risk

17-Alpha Hydroxyprogesterone 250 mg/mL in Castor Oil Injection

Lack of Assurance of Sterility: A recall of all compounded sterile preparations within expiry is being initiated due to observations associated with poor sterile production practices resulting in a lack of sterility assurance for their finished drugs.

Terminated Sterility / contamination Kalman Health & Wellness, Inc. dba Essential Wellness Pharma D-299-2016
Class II · Moderate risk

Acetylcysteine 10% Oph Solution

Lack of Assurance of Sterility: A recall of all compounded sterile preparations within expiry is being initiated due to observations associated with poor sterile production practices resulting in a lack of sterility assurance for their finished drugs.

Terminated Sterility / contamination Kalman Health & Wellness, Inc. dba Essential Wellness Pharma D-298-2016
Class II · Moderate risk

0.9% Sodium Chloride Injection

Lack of Assurance of Sterility: Recalling firm reported a complaint for mold on the interior surface of the overpouch.

Terminated Sterility / contamination Baxter Healthcare Corporation NDC 0338-0049-38 D-1816-2015
Class I · High risk

MIRACLE DIET 30 capsules

Marketed Without An Approved NDA/ANDA: Miracle Diet 30 was found to contain undeclared phenolphthalein, a drug product once contained in over-the-counter laxatives but was taken off the U.S. market due to safety concerns, making this product an unapproved drug.

Ongoing Chemical / undeclared The One Minute Miracle Inc D-0230-2016
Class I · High risk

MIRACLE ROCK 48 capsules

Marketed Without An Approved NDA/ANDA: Miracle Rock 48 was found to contain undeclared thiosildenafil, an analogue of an FDA approved drug for male erectile dysfunchtion making this product an unapproved drug.

Ongoing Chemical / undeclared The One Minute Miracle Inc D-0229-2016
Class II · Moderate risk

1% Lidocaine HCl Injection

Presence of Particulate Matter: particulate matter identified as iron oxide, was found embedded in the neck of glass vials.

Ongoing Particulate / foreign matter Hospira, Inc. NDC 0409-4279-02 D-1815-2015
Class II · Moderate risk

Blephamide

Presence of Particulate Matter: Due to customer complaints of small black particles, identified as part of the ointment tube cap, generated by the action of unscrewing the cap from the aluminum tube and potentially introducing the particle into the product.

Terminated Particulate / foreign matter Allergan Sales, LLC NDC 0023-0313-04 D-1820-2015
Class II · Moderate risk

FML (fluorometholone ophthalmic ointment)

Presence of Particulate Matter: Due to customer complaints of small black particles, identified as part of the ointment tube cap, generated by the action of unscrewing the cap from the aluminum tube and potentially introducing the particle into the product.

Terminated Particulate / foreign matter Allergan Sales, LLC NDC 0023-0316-04 D-1819-2015
Class II · Moderate risk

Refresh P.M.

Presence of Particulate Matter: Due to customer complaints of small black particles, identified as part of the ointment tube cap, generated by the action of unscrewing the cap from the aluminum tube and potentially introducing the particle into the product.

Terminated Particulate / foreign matter Allergan Sales, LLC NDC 0023-0240-04 D-1818-2015
Class II · Moderate risk

Refresh Lacri-Lube

Presence of Particulate Matter: Due to customer complaints of small black particles, identified as part of the ointment tube cap, generated by the action of unscrewing the cap from the aluminum tube and potentially introducing the particle into the product.

Terminated Particulate / foreign matter Allergan Sales, LLC NDC 0023-0312-04 D-1817-2015
Class I · High risk

Xcellerator

Marketed Without an Approved NDA/ANDA: FDA sampling confirmed the presence of Salicylic acid in dietary supplements.

Terminated Unapproved drug Novacare, LLC D-0973-2016
Class I · High risk

TruTrim (product not labeled)

Marketed Without an Approved NDA/ANDA: FDA sampling confirmed the presence of Salicylic acid in dietary supplements.

Terminated Unapproved drug Novacare, LLC D-0967-2016

Recalls by year